Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ARCA BIOPHARMA -- ABIO 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ANIK , ABIO , GNVC , GTCB , LXRX , NBIX , ORCH -- DRUGS 3 $4 View Abstract
6-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Arca Biopharma Inc 43 $65 View Abstract
29-Oct-09 Global Markets Direct Global Markets Direct ARCA biopharma, Inc. - pharmaceuticals & healthcare - Deals and Alliances Profile 13 $250 View Abstract
28-Oct-09 Global Markets Direct Global Markets Direct ARCA biopharma, Inc. Financial Analysis Review 12 $300 View Abstract
15-Oct-09 New Constructs, LLC N/A ABIO: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $50 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract

Independent Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ARCA BIOPHARMA -- ABIO 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ANIK , ABIO , GNVC , GTCB , LXRX , NBIX , ORCH -- DRUGS 3 $4 View Abstract
6-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Arca Biopharma Inc 43 $65 View Abstract
29-Oct-09 Global Markets Direct Global Markets Direct ARCA biopharma, Inc. - pharmaceuticals & healthcare - Deals and Alliances Profile 13 $250 View Abstract
28-Oct-09 Global Markets Direct Global Markets Direct ARCA biopharma, Inc. Financial Analysis Review 12 $300 View Abstract
15-Oct-09 New Constructs, LLC N/A ABIO: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $50 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.